MARKET

PBE

PBE

Invesco Dynamic Biotech & Genome Etf
NYSEARCA

Real-time Quotes | Provided by Morningstar

59.11
+1.37
+2.37%
Closed 16:00 07/01 EDT
OPEN
59.12
PREV CLOSE
57.74
HIGH
59.12
LOW
57.97
VOLUME
3.72K
TURNOVER
112.59K
52 WEEK HIGH
79.92
52 WEEK LOW
51.39
TOTAL ASSET
224.96M
YTD YIELD
-25.26%
1D
5D
1M
3M
1Y
5Y
Best Biotech ETFs for Q3 2022
Biotech companies use or modify biological processes to create new pharmaceuticals or therapies. Some of the most prominent biotech companies include Vertex Pharmaceuticals Inc. (VRTX) and Regeneron Pharmaceuticals Inc.
Investopedia · 06/04 03:59
SEC Planned Crackdown on ‘Misleading’ Funds Goes Far Beyond ESG
Bloomberg · 05/26 19:34
The Psychology Behind the Market Selloff
Bloomberg · 05/26 08:00
Biotech ETF hovers near one-year trading low but attracts over $1B YTD
Biotechnology exchange traded fund SPDR S&P Biotech ETF (NYSEARCA:XBI) hovers near its one-year trading low, but the investment community has shown recent interest in the fund as the ETF has experienced
Seekingalpha · 04/21 14:47
Bitcoin ETFs Set to Roll Out in Australia to Test Crypto Demand
Bloomberg · 04/20 19:00
A Bond Hedge Crushes All Rival ETFs to Post 57% Gain
Bloomberg · 04/20 13:52
Roundhill Waits Eight Months to Launch Its WEED ETF on 4/20
Bloomberg · 04/20 13:00
Quant Momentum Funds Are Slammed Again in a New Fed-Linked Study
Bloomberg · 02/12 13:15
More
No Data
Learn about the latest financial forecast of PBE. Analyze the recent business situations of Invesco Dynamic Biotech & Genome Etf through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
05/31/2022
3 Year
Morningstar
05/31/2022
5 Year
Morningstar
05/31/2022
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-14.8600%
--
1-Month
-9.0290%
--
3-Month
-4.8989%
--
6-Month
-23.3353%
--
1-Year
-22.4081%
--
3-Year
16.0463%
--
5-Year
31.2990%
--
10-Year
173.8530%
--
No Data
No Data
No Data
Profile
Fund Name
Invesco Dynamic Biotech & Genome Etf
Inception Date
2005-06-23
Benchmark
Dynamic Biotech&Genome Intellidex TR USD
Advisor Company
Invesco Capital Management LLC
Custodian
Bank of New York Mellon
Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Pratik Doshi